The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
Open accessAbstract
Glycogen synthase kinase 3 (GSK‐3) was initially described as a key enzyme involved in glycogen metabolism, but is now known to regulate a diverse array of cell functions. Two forms of the enzyme, GSK‐3α and GSK‐3β, have been previously identified. Small molecules inhibitors of GSK‐3 may, therefore, have several therapeutic uses, including the treatment of neurodegenerative diseases, diabetes type II, bipolar disorders, stroke, cancer, and chronic inflammatory disease. As there is lot of recent literature dealing with the involvement of GSK‐3 in the molecular pathways of different diseases, this review is mainly focused on the new GSK‐3 inhibitors discovered or specifically developed for this enzyme, their chemical structure, synthesis, and structure–activity relationships, with the aim to provide some clues for the future optimization of these promising drugs. © 2002 Wiley Periodicals, Inc. Med Res Rev, 22, No. 4, 373–384, 2002; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/med.10011
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Ikeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246
Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 897
Hoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., et al. (1999) · Nature Cell Biology · doi:10.1038/9035 · Cited by 809
Leclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y.-Z., Mandelkow, E.-M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002466200 · Cited by 723
Frame, S., Cohen, P., & Biondi, R. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00253-2 · Cited by 701
Crystal Structure of Glycogen Synthase Kinase 3β
Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., & Pearl, L. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00374-9 · Cited by 674
Cohen, P. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02473.x · Cited by 634
Lithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
Ryves, W. J., & Harwood, A. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4169 · Cited by 493
The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus
Rothwarf, D. M., & Karin, M. (1999) · Science's STKE · doi:10.1126/stke.1999.5.re1 · Cited by 488
The molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Maccioni, R. B., Muñoz, J. P., & Barbeito, L. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00316-2 · Cited by 474
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 469
Martinez, A., Alonso, M., Castro, A., Pérez, C., & Moreno, F. J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011020u · Cited by 455
Self-citationMeijer, L., Thunnissen, A.-M., White, A., Garnier, M., Nikolic, M., Tsai, L.-H., Walter, J., Cleverley, K., Salinas, P., Wu, Y.-Z., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00063-6 · Cited by 454
Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine
Tang, W., & Eisenbrand, G. (1992) · Cited by 453
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 438
Structure of GSK3beta reveals a primed phosphorylation mechanism.
ter Haar, E., Coll, J. T., Austen, D. A., Hsiao, H.-M., Swenson, L. L., & Jain, J. (2001) · Nature Structural Biology · doi:10.1038/89624 · Cited by 407
Glucose Sensing in Pancreatic β-Cells
Schuit, F. C., Huypens, P., Heimberg, H., & Pipeleers, D. G. (2001) · Diabetes · doi:10.2337/diabetes.50.1.1 · Cited by 405
Welsh, G. I., & Proud, C. G. (1993) · Biochemical Journal · doi:10.1042/bj2940625 · Cited by 404
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
Haq, S., Choukroun, G., Kang, Z. B., Ranu, H., Matsui, T., Rosenzweig, A., Molkentin, J. D., Alessandrini, A., Woodgett, J., Hajjar, R., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.1.117 · Cited by 392
Cross, D. A. E., Culbert, A. A., Chalmers, K. A., Facci, L., Skaper, S. D., & Reith, A. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00251.x · Cited by 377
Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25
Leost, M., Schultz, C., Link, A., Wu, Y., Biernat, J., Mandelkow, E., Bibb, J. A., Snyder, G. L., Greengard, P., Zaharevitz, D. W., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01673.x · Cited by 376
Hernández, F., Borrell, J., Guaza, C., Avila, J., & Lucas, J. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01269.x · Cited by 372
Cyclic AMP Promotes Neuronal Survival by Phosphorylation of Glycogen Synthase Kinase 3β
Li, M., Wang, X., Meintzer, M. K., Laessig, T., Birnbaum, M. J., & Heidenreich, K. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9356-9363.2000 · Cited by 363
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Mohideen, P., Carter, L., & Henry, R. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.263 · Cited by 357
Schultz, C., Link, A., Leost, M., Zaharevitz, D. W., Gussio, R., Sausville, E. A., Meijer, L., & Kunick, C. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900570 · Cited by 334
Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
Muñoz-Montaño, J. R., Moreno, F. J., Avila, J., & Dı́az-Nido, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00688-1 · Cited by 322
Judging a Protein by More Than Its Name: GSK-3
Woodgett, J. R. (2001) · Science's STKE · doi:10.1126/stke.2001.100.re12 · Cited by 279
Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., & Dı́az-Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270
Zaharevitz, D. W., Gussio, R., Leost, M., Senderowicz, A. M., Lahusen, T. J., Kunick, C., Meijer, L., & Sausville, E. A. (1999) · PubMed · Cited by 225
GSK3, a master switch regulating cell-fate specification and tumorigenesis
Kim, L., & Kimmel, A. R. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00120-9 · Cited by 219
Lochhead, P. A., Coghlan, M., Rice, S. Q. J., & Sutherland, C. (2001) · Diabetes · doi:10.2337/diabetes.50.5.937 · Cited by 219
Bax, B., Carter, P. S., Lewis, C., Guy, A. R., Bridges, A., Tanner, R., Pettman, G., Mannix, C., Culbert, A. A., Brown, M. J. B., et al. (2001) · Structure · doi:10.1016/s0969-2126(01)00679-7 · Cited by 200
Flaherty, D. B., Soria, J., Tomasiewicz, H. G., & Wood, J. G. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001101)62:3<463::aid-jnr16>3.0.co;2-7 · Cited by 178
Current Therapies and Emerging Targets for the Treatment of Diabetes
Wagman, A., & Nuss, J. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397915 · Cited by 175
Lovestone, S., Davis, D. R., Webster, M.-T., Kaech, S., Brion, J., Matus, A. I., & Anderton, B. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00183-8 · Cited by 166
3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)
Smith, D. G., Buffet, M., Fenwick, A. E., Haigh, D., Ife, R. J., Saunders, M., Slingsby, B. P., Stacey, R., & Ward, R. W. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00721-6 · Cited by 161
Lithium therapy and signal transduction
Williams, R. S. B., & Harwood, A. J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01428-5 · Cited by 158
Xavier, I. J., Mercier, P. A., McLoughlin, C., Ali, A., Woodgett, J. R., & Ovsenek, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002169200 · Cited by 155
Hers, I., Tavaré, J. M., & Denton, R. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01389-7 · Cited by 144
Neurofibrillary tangles and tau phosphorylation
Brion, J., Anderton, B. H., Authelet, M., Dayanandan, R., Leroy, K., Lovestone, S., Octave, J., Pradier, L., Touchet, N., & Tremp, G. L. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670081 · Cited by 139
Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers
Manji, H. K., Moore, G. J., & Chen, G. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.41.s107 · Cited by 138
Damiens, E., Baratte, B., Marie, D., Eisenbrand, G., & Meijer, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204503 · Cited by 134
A Structure-Based Library Approach to Kinase Inhibitors
Norman, T., Gray, N. S., Koh, J. T., & Schultz, P. G. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9614934 · Cited by 133
Mudher, A. K., Chapman, S. C., Richardson, J. C., Asuni, A. A., Gibb, G., Pollard, C. C., Killick, R., Iqbal, T. A., Raymond, F. L., Varndell, I. M., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-04987.2001 · Cited by 127
Expression analysis of glycogen synthase kinase‐3 in human tissues
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. C. (1999) · Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00083.x · Cited by 126
Low GSK-3 activity in frontal cortex of schizophrenic patients
Kozlovsky, N., Belmaker, R. H., & Agam, G. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00174-2 · Cited by 122
Identification of the Axin and Frat Binding Region of Glycogen Synthase Kinase-3
Fraser, E., Young, N., Dajani, R. B., Franca‐Koh, J., Ryves, J., Williams, R. S. B., Yeo, M., Webster, M.-T., Richardson, C. D., Smalley, M. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109462200 · Cited by 113
Mora, A., Sabio, G., González‐Polo, R. A., Cuenda, A., Alessi, D. R., Alonso, J. C., Fuentes, J. M., Soler, G., & Centeno, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00410.x · Cited by 109
Glycogen Synthase Kinase-3β Regulates Presenilin 1 C-terminal Fragment Levels
Kirschenbaum, F., Hsu, S.-C., Cordell, B., & McCarthy, J. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102849200 · Cited by 101
Forlenza, O. V., Spink, J. M., Dayanandan, R., Anderton, B. H., Olesen, O. F., & Lovestone, S. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070034 · Cited by 101
Integrin-linked kinase (ILK): a “hot” therapeutic target
Yoganathan, T., Costello, P., Chen, X., Jabali, M. D., Yan, J., Leung, D., Zhang, Z., Yee, A., Dedhar, S., & Sanghera, J. S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00444-5 · Cited by 98
Culbert, A. A., Brown, M. J. B., Frame, S., Hagen, T., Cross, D. A. E., Bax, B. D., & Reith, A. D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02990-8 · Cited by 85
Therapeutic Strategies in Alzheimer’s Disease: Ml Muscarinic Agonists
Fisher, A. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.84.101 · Cited by 85
N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors
Martı́nez, A., Fernandez, E., Castro, A., Conde, S., Rodrı́guez-Franco, M. I., Baños, J.-E., & Badı́a, A. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)01166-1 · Cited by 79
Self-citationHuachun, S., Lu, Z., Li, Y., Ru, B., Wang, W., & Chen, J. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02206-6 · Cited by 73
Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. (1999) · Genomics · doi:10.1006/geno.1999.5875 · Cited by 68
Fisher, A., Michaelson, D. M., Brandeis, R., Haring, R., CHAPMAN, S., & Pittel, Z. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06941.x · Cited by 64
Missing Links in GSK3 Regulation
Dominguez, I. M., & Green, J. B. A. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0317 · Cited by 64
Russ, C., Lovestone, S., & Powell, J. F. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000852 · Cited by 59
Breton, J., & Chabot‐Fletcher, M. (1997) · PubMed · Cited by 58
Lithium-related genetics of bipolar disorder
Detera-Wadleigb, S. D. (2001) · Annals of Medicine · doi:10.3109/07853890108998756 · Cited by 49
Castro, A., & Martínez, A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.10.1519 · Cited by 41
Self-citationRatnakumari, L., Vysotskaya, T. N., Duch, D. S., & Hemmings, H. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01532-5 · Cited by 35
Moreno, F., Mu�oz-Monta�o, J. R., & Ávila, J. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229744 · Cited by 33
Davies, G., Jiang, W., & Mason, M. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.843 · Cited by 23
Traditional and Modern Medicine
(2016) · CRC Press eBooks · doi:10.1201/9781315372129-5 · Cited by 5
Cited by
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 808
Multitargeting by curcumin as revealed by molecular interaction studies
Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., Priyadarsini, I. K., & Aggarwal, B. B. (2011) · Natural Product Reports · doi:10.1039/c1np00051a · Cited by 669
Pharmacological inhibitors of glycogen synthase kinase 3
MEIJER, L., FLAJOLET, M., & GREENGARD, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.006 · Cited by 584
Beurel, E., & Jope, R. S. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.006 · Cited by 541
Metadata
- Authors
- Martinez, A., Castro, A., Dorronsoro, I., & Alonso, M.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2002-06-06
- Volume
- 22
- Issue
- 4
- Pages
- 373-384
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2153250061
- Cited by
- 333
- References
- 75
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.